Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2732) 2732
Magazine Article (19) 19
Newspaper Article (18) 18
Newsletter (12) 12
Book Chapter (7) 7
Conference Proceeding (2) 2
Dissertation (2) 2
Paper (1) 1
Publication (1) 1
Transcript (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2160) 2160
science & technology (1955) 1955
life sciences & biomedicine (1892) 1892
female (1832) 1832
alendronate - therapeutic use (1806) 1806
alendronate (1163) 1163
osteoporosis (1076) 1076
middle aged (1049) 1049
aged (1029) 1029
bone density conservation agents - therapeutic use (954) 954
male (836) 836
biological and medical sciences (737) 737
osteoporosis, postmenopausal - drug therapy (721) 721
bone density - drug effects (695) 695
medical sciences (681) 681
osteoporosis - drug therapy (652) 652
endocrinology & metabolism (588) 588
bisphosphonates (525) 525
alendronate - administration & dosage (510) 510
animals (499) 499
bone density (489) 489
diphosphonates - therapeutic use (481) 481
alendronate - adverse effects (462) 462
pharmacology. drug treatments (426) 426
aged, 80 and over (409) 409
alendronate - pharmacology (408) 408
orthopedics (388) 388
adult (380) 380
treatment outcome (366) 366
abridged index medicus (354) 354
risk factors (340) 340
bone density conservation agents - adverse effects (321) 321
drug therapy (310) 310
bones, joints and connective tissue. antiinflammatory agents (305) 305
fractures (304) 304
medicine & public health (299) 299
bone density conservation agents - administration & dosage (297) 297
etidronic acid - therapeutic use (288) 288
general & internal medicine (286) 286
bones (284) 284
diseases of the osteoarticular system (282) 282
medicine, general & internal (281) 281
rheumatology (271) 271
etidronic acid - analogs & derivatives (268) 268
fractures, bone - prevention & control (249) 249
pharmacology & pharmacy (246) 246
rats (239) 239
risedronate sodium (238) 238
bone mineral density (235) 235
alendronic acid (221) 221
osteoporosis. osteomalacia. paget disease (220) 220
health aspects (214) 214
administration, oral (210) 210
postmenopausal women (209) 209
time factors (208) 208
double-blind method (206) 206
bone density conservation agents - pharmacology (198) 198
care and treatment (198) 198
dentistry (196) 196
endocrinology (195) 195
absorptiometry, photon (192) 192
analysis (188) 188
bisphosphonate (186) 186
diphosphonates - administration & dosage (179) 179
research (179) 179
drug therapy, combination (175) 175
bone remodeling - drug effects (173) 173
diphosphonates - adverse effects (171) 171
osteoporosis - prevention & control (170) 170
follow-up studies (164) 164
fundamental and applied biological sciences. psychology (160) 160
drug administration schedule (158) 158
bone and bones - drug effects (152) 152
osteoporosis, postmenopausal - complications (150) 150
retrospective studies (145) 145
surgery (144) 144
dentistry, oral surgery & medicine (139) 139
radiography (139) 139
density (138) 138
osteoporosis - complications (133) 133
dosage and administration (131) 131
prospective studies (131) 131
diphosphonates (129) 129
raloxifene hydrochloride - therapeutic use (127) 127
randomized controlled trials as topic (125) 125
phosphonates (124) 124
vitamin d - therapeutic use (124) 124
alkaline phosphatase - blood (122) 122
osteoporosis, postmenopausal - physiopathology (122) 122
osteoporosis, postmenopausal - prevention & control (122) 122
biomarkers - blood (120) 120
medicine, research & experimental (119) 119
research & experimental medicine (119) 119
teriparatide - therapeutic use (118) 118
calcium - therapeutic use (115) 115
diphosphonates - pharmacology (115) 115
dose-response relationship, drug (114) 114
risedronate (114) 114
bone resorption - drug therapy (113) 113
mice (112) 112
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2624) 2624
Japanese (66) 66
German (59) 59
Spanish (34) 34
French (23) 23
Chinese (22) 22
Polish (12) 12
Portuguese (12) 12
Italian (10) 10
Norwegian (6) 6
Dutch (5) 5
Danish (4) 4
Hungarian (4) 4
Croatian (3) 3
Serbian (2) 2
Slovak (2) 2
Turkish (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis
: Results of a 2-year study
by Rizzoli, R and Rizzoli, R and Chapurlat, R D and Chapurlat, R D and Laroche, J.-M and Laroche, J.-M and Krieg, M A and Krieg, M A and Thomas, T and Thomas, T and Frieling, I and Frieling, I and Boutroy, S and Boutroy, S and Laib, A and Laib, A and Bock, O and Bock, O and Felsenberg, D and Felsenberg, D
Osteoporosis international, ISSN 0937-941X, 1/2012, Volume 23, Issue 1, pp. 305 - 315
Osteoporosis | Medicine & Public Health | Alendronate | Orthopedics | Gynecology | Rheumatology | Finite elements analysis | Strontium ranelate | HR-pQCT | Microstructure | Endocrinology | HRpQCT | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Bone and Bones - pathology | Thiophenes - therapeutic use | Radius - pathology | Humans | Middle Aged | Osteoporosis, Postmenopausal - pathology | Tomography, X-Ray Computed | Tibia - pathology | Alendronate - therapeutic use | Bone and Bones - drug effects | Bone and Bones - diagnostic imaging | Osteoporosis, Postmenopausal - diagnostic imaging | Radius - drug effects | Organometallic Compounds - therapeutic use | Female | Finite Element Analysis | Lumbar Vertebrae - physiopathology | Double-Blind Method | Tibia - diagnostic imaging | Bone Density Conservation Agents - therapeutic use | Thiophenes - pharmacology | Tibia - drug effects | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Bone Density - drug effects | Alendronate - pharmacology | Femur Neck - physiopathology | Osteoporosis, Postmenopausal - physiopathology | Aged | Organometallic Compounds - pharmacology | Radius - diagnostic imaging | Structure | Bones | Analysis | Index Medicus | Dual energy X-ray absorptiometry | Radius | Transformation | Bone turnover | Bisphosphonates | Stress | Post-menopause | Strontium | Alendronic acid | Fractures | Computed tomography | Tibia | Risk assessment | Bone mineral density | Bone strength | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Postmenopausal osteoporosis
by Diab, Dima L and Watts, Nelson B
Current opinion in endocrinology, diabetes, and obesity, ISSN 1752-296X, 12/2013, Volume 20, Issue 6, pp. 501 - 509
Fractures | Treatment | Diagnosis | Postmenopausal osteoporosis | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Raloxifene Hydrochloride - therapeutic use | Teriparatide - therapeutic use | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Calcitonin - therapeutic use | Alendronate - therapeutic use | Accidental Falls - prevention & control | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Osteoporosis, Postmenopausal - prevention & control | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Assessment | Risk Reduction Behavior | Risk Factors | Bone Density Conservation Agents - therapeutic use | Denosumab | Osteoporosis, Postmenopausal - drug therapy | Bone Density - drug effects | Medication Adherence | Calcium - therapeutic use | Aged | Vitamin D - therapeutic use | Dietary Supplements | Fractures, Bone - prevention & control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity
by Wu, Xiaoyan and Hu, Zhenhua and Nizzero, Sara and Zhang, Guodong and Ramirez, Maricela R and Shi, Ce and Zhou, Jin and Ferrari, Mauro and Shen, Haifa
Journal of controlled release, ISSN 0168-3659, 12/2017, Volume 268, pp. 92 - 101
Bone marrow | Decitabine | Arsenic trioxide | Delivery | Nanoparticle | Myelodysplastic syndrome | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nanoparticles - chemistry | Apoptosis - drug effects | Oxides - chemistry | Azacitidine - chemistry | Phosphatidylethanolamines - therapeutic use | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polyethylene Glycols - therapeutic use | Alendronate - chemistry | Alendronate - therapeutic use | Tissue Distribution | Arsenicals - therapeutic use | Nanoparticles - therapeutic use | Bone and Bones - metabolism | Phosphatidylethanolamines - pharmacokinetics | Bone Marrow Cells - drug effects | Antineoplastic Agents - pharmacokinetics | Arsenicals - pharmacokinetics | Alendronate - pharmacokinetics | Myelodysplastic Syndromes - drug therapy | Oxides - administration & dosage | Azacitidine - administration & dosage | Oxides - therapeutic use | Cell Survival - drug effects | Arsenic Trioxide | Azacitidine - pharmacokinetics | Myelodysplastic Syndromes - metabolism | Cells, Cultured | Polyethylene Glycols - pharmacokinetics | Azacitidine - analogs & derivatives | Mice, Transgenic | Phosphatidylethanolamines - administration & dosage | Antineoplastic Agents - chemistry | Polyethylene Glycols - administration & dosage | Oxides - pharmacokinetics | Arsenicals - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Arsenicals - chemistry | Nanoparticles - administration & dosage | Phosphatidylethanolamines - chemistry | Alendronate - administration & dosage | Azacitidine - therapeutic use | Medical research | Medical colleges | Medical examination | Arsenic | Analysis | Medicine, Experimental | Hematopoietic stem cells | Blood | Index Medicus | delivery | nanoparticle | decitabine | arsenic trioxide | bone marrow
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prevention and treatment of postmenopausal osteoporosis
by Tella, Sri Harsha and Gallagher, J. Christopher
The Journal of steroid biochemistry and molecular biology, ISSN 0960-0760, 07/2014, Volume 142, pp. 155 - 170
BMD | Osteoporosis | Treatment | Diagnosis | Risk factors | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Estrogen Replacement Therapy | Osteoporosis, Postmenopausal - diagnosis | Teriparatide - therapeutic use | Humans | Middle Aged | Risk Factors | Calcitonin - therapeutic use | Bone Remodeling - physiology | Denosumab | Osteoporosis, Postmenopausal - drug therapy | Alendronate - therapeutic use | Antibodies, Monoclonal, Humanized | Bone Density - drug effects | Fractures, Bone - etiology | RANK Ligand - antagonists & inhibitors | Selective Estrogen Receptor Modulators - therapeutic use | Aged, 80 and over | Diphosphonates - therapeutic use | Female | Osteoporosis, Postmenopausal - physiopathology | Osteoprotegerin - therapeutic use | Aged | Osteoporosis, Postmenopausal - prevention & control | Prevention | Care and treatment | Postmenopausal women | Phosphonates | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS)
by Di Gregorio, S and Del Rio, L and Rodriguez-Tolra, J and Bonel, E and García, M and Winzenrieth, R
Bone (New York, N.Y.), ISSN 8756-3282, 2015, Volume 75, pp. 138 - 143
Orthopedics | Osteoporosis treatments | TBS (trabecular bone score) | Bone mineral density | Bone microarchitectural texture | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Teriparatide - therapeutic use | Humans | Middle Aged | Bone Density Conservation Agents - therapeutic use | Male | Osteoporosis - drug therapy | Absorptiometry, Photon | Alendronate - therapeutic use | Denosumab - therapeutic use | Risedronate Sodium - therapeutic use | Bone Density - drug effects | Calcium - therapeutic use | Osteoporosis - diagnostic imaging | Female | Aged | Vitamin D - therapeutic use | Dietary Supplements | Longitudinal Studies | Testosterone - therapeutic use | Osteoporosis | Bones | Density | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial
by Jensen, T W and Hansen, M S and Hørslev-Petersen, K and Hyldstrup, L and Abrahamsen, B and Langdahl, B and Zerahn, B and Pødenphant, J and Stengaard-Petersen, K and Junker, P and Østergaard, M and Lottenburger, T and Ellingsen, T and Andersen, L S and Hansen, I and Skjødt, H and Pedersen, J K and Lauridsen, U B and Svendsen, A J and Tarp, U and Lindegaard, H and Jurik, Anne Grethe and Vestergaard, Aage and Hetland, M L and Cimestra Study Grp and Cimestra study group and the Cimestra study group
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2014, Volume 73, Issue 6, pp. 1123 - 1129
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Glucocorticoids - administration & dosage | Betamethasone - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Alendronate - therapeutic use | Bone Diseases, Metabolic - drug therapy | Young Adult | Arthritis, Rheumatoid - drug therapy | Adult | Female | Drug Therapy, Combination | Antirheumatic Agents - therapeutic use | Bone Density | Lumbar Vertebrae - metabolism | Double-Blind Method | Lumbar Vertebrae - diagnostic imaging | Bone Diseases, Metabolic - prevention & control | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Disease Progression | Bone Resorption - prevention & control | Radiography | Cyclosporine - therapeutic use | Injections, Intra-Articular | Aged | Complications and side effects | Care and treatment | Corticosteroids | Alendronate | Rheumatoid arthritis | Dosage and administration | Bone diseases | Risk factors | Osteoporosis | Rheumatism | Bone density | Inflammation | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up)
by Leder, Benjamin Z and Tsai, Joy N and Jiang, Linda A and Lee, Hang
Bone (New York, N.Y.), ISSN 8756-3282, 2017, Volume 98, pp. 54 - 58
Orthopedics | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Teriparatide - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Alendronate - therapeutic use | Denosumab - therapeutic use | Bone Density - drug effects | Diphosphonates - therapeutic use | Postmenopause | Female | Aged | Imidazoles - therapeutic use | Osteoporosis | Medical research | Phosphonates | Medicine, Experimental | Bones | Postmenopausal women | Density | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
by Anastasilakis, Athanasios D and Anastasilakis, Athanasios D and Polyzos, Stergios A and Polyzos, Stergios A and Makras, Polyzois and Makras, Polyzois
European journal of endocrinology, ISSN 0804-4643, 07/2018, Volume 179, Issue 1, pp. R31 - R45
Teriparatide - therapeutic use | Cost-Benefit Analysis | Humans | Osteoporotic Fractures - prevention & control | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Zoledronic Acid | Imidazoles - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Alendronate - therapeutic use | Denosumab - therapeutic use | Jaw | Femur | Renal function | Bone remodelling | Osteonecrosis | Bone turnover | Bisphosphonates | Patients | Hip | Post-menopause | Bone resorption | Osteoporosis | Alendronic acid | Fractures | Parathyroid hormone | Zoledronic acid | Bone mineral density
Journal Article
Details down arrow
9. Full Text Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances
by Segal, Ehud and Pan, Huaizhong and Benayoun, Liat and Kopečková, Pavla and Shaked, Yuval and Kopeček, Jindřich and Satchi-Fainaro, Ronit
Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 19, pp. 4450 - 4463
Advanced Basic Science | Dentistry | TNP-470 | Alendronate | Osteosarcoma | HPMA copolymer | Polymer therapeutics | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Osteosarcoma - drug therapy | Body Weight | Humans | Male | Antineoplastic Agents - therapeutic use | Sesquiterpenes - therapeutic use | Alendronate - chemistry | Alendronate - therapeutic use | Tissue Distribution | Cyclohexanes - therapeutic use | Angiogenesis Inhibitors - therapeutic use | Cyclohexanes - chemistry | Molecular Structure | Bone Neoplasms - drug therapy | Bone Density Conservation Agents - chemistry | Sesquiterpenes - chemistry | Bone Density Conservation Agents - therapeutic use | Materials Testing | Antineoplastic Agents - chemistry | Acrylamides - chemistry | Animals | Cell Line, Tumor | Polymers - chemistry | Mice | Mice, Inbred BALB C | Angiogenesis Inhibitors - chemistry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights